Additional file 2: Figure S2. of Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma

Authors :: Shutaro Yamada
Imura, Yoshinori
Nakai, Takaaki
Nakai, Sho
Yasuda, Naohiro
Kaneko, Keiko
Hidetatsu Outani
Takenaka, Satoshi
Hamada, Kenichiro
Myoui, Akira
Nobuhito Araki
Ueda, Takafumi
Itoh, Kazuyuki
Yoshikawa, Hideki
Naka, Norifumi
Publication Year :: 2017
Publisher :: Figshare, 2017.
Abstract: SYO-1 and HS-SY-II (PDGFRα-dependent) SS cells were treated with 0.001–10 μM of TAS-115 or control (0.1% DMSO) for 3 h, followed by an additional treatment with 10-ng/ml rhPDGF-BB for the last 15 min. (PPTX 178 kb)

Full Text Access

Tools